TY - JOUR T1 - Tofacitinib for Treating Rheumatoid Arthritis After the Failure of Disease-Modifying Anti-rheumatic Drugs: An Evidence Review Group Perspective of a NICE Single Technology Appraisal JO - PharmacoEconomics UR - http://eprints.whiterose.ac.uk/128751/ PY - 2018/03/15 AU - Uttley L AU - Bermejo I AU - Ren S AU - Martyn-St James M AU - Wong R AU - Scott DL AU - Young A AU - Stevenson M ED - DO - DOI: 10.1007/s40273-018-0639-0 PB - Springer Science and Business Media LLC VL - 36 IS - 9 SP - 1063 EP - 1072 Y2 - 2025/04/30 ER -